Clinical trial
Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Drug Testing Sensitivity of Solid Tumors
NCT00243685 is registered in ClinicalTrials.gov with Pierian Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of the Microculture Kinetic (MiCK) Assay for Apoptosis to Drug Testing Sensitivity of Solid Tumors
- Lead sponsor
- Pierian Biosciences
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- May 31, 2009
- Enrollment
- 150 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast neoplasms, lung neoplasms, ovarian neoplasms, sarcoma, soft tissue